Zacks Investment Research on MSN
PLSE wins FDA IDE approval to launch nPulse AF ablation study trial
Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to initiate its nPulse Cardiac Catheter Ablation System study for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback